Evidence map›Paper›PMID 29299202›Full record

ArticleIranian journal of basic medical sciences2017

The role of TSG-6 and uroplakin III in bladder pain syndrome/ interstitial cystitis in rats and humans.

Yi-Song Lv, Rui Gao, Qing-Ming Lin, Tao Jiang, Qin Chen, Song-Xi Tang, Hou-Ping Mao, Hui-Liang Zhou, Lin-Sheng Cao

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yi-Song LvDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Rui GaoDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Qing-Ming LinDepartment of Emergency Medicine, Fujian Provincial Hospital, Fuzhou 350005, China.
Tao JiangDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Qin ChenDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Song-Xi TangDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Hou-Ping MaoDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Hui-Liang ZhouDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Lin-Sheng CaoDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
First Affiliated Hospital of Fujian Medical University · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe investigated the relationship between the expression of tumor necrosis factor-inducible gene 6 (TSG-6) with inflammation and integrity of the bladder epithelium in the bladder tissues of patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and the mechanism of action using a rat model of BPS/IC. MATERIALS AND

methodsExpression of TSG-6 and uroplakin III was determined by immuno- histochemistry of bladder biopsy samples from control human subjects and patients with verified BPS/IC. Our rat model of BPS/IC was employed to measure the perfusion of bladders with hyaluronidase, and assessment of the effect of TSG-6 administration on disease progression. Treatment effects were assessed by measurement of metabolic characteristics, RT-PCR of TGR-6 and interleukin-6, bladder histomorphology, and immunohistochemistry of TGR-6 and uroplakin III.

resultsThe bladders of patients with BPS/IC had lower expression of uroplakin III and higher expression of TSG-6 than controls. Rats treated with hyaluronidase for 1 week developed the typical signs and symptoms of BPS/IC, and rats treated with hyaluronidase for 4 weeks had more serious disease. Administration of TSG-6 reversed the effects of hyaluronidase and protected against disease progression.

conclusionOur results indicate that TSG-6 plays an important role in maintaining the integrity of the bladder epithelial barrier.

Indexed as

Bladder pain syndrome/-interstitial cystitisImmunofluorescence – stainingInterleukin-6TSG-6Uroplakin III

Identifiers

PMID29299202
PMCPMC5749359
OpenAlexW2769718984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.